3097 Safety and efficacy of first-line nivolumab (NIVO) and ipilimumab (IPI) in non-small cell lung cancer (NSCLC) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hellmann, MD
  • Rizvi, N
  • Gettinger, SN
  • Goldman, J
  • Chow, LQ
  • Juergens, Rosalyn
  • Borghaei, H
  • Brahmer, J
  • Shen, Y
  • Harbison, CT
  • Nathan, F
  • Ready, NE
  • Antonia, SJ

publication date

  • September 2015